IBS-C Drug Market Report

Europe IBS-C Drug Market Size, Status and Forecast 2014-2026

  • POSTDATE：Mar 28, 2020
  • PAGES：163
  • REPORT CODE：GMM523882
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The IBS-C Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.7% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe IBS-C Drug Market Segmentations:

    By Player:

    • Catalent Pharmaceuticals Solutions

    • Ono Pharmaceutical

    • Ironwood Pharmaceuticals

    • The Menarini Group

    • Astrazeneca

    • Salix Pharmaceuticals

    • Ardelyx

    • Norgine

    • Ferring BV

    • Prometheus Laboratories

    • Nestle

    • Actavis Nordic

    • Teva Pharmaceutical Industries

    • Astellas Pharmaceuticals

    • Sucampo Pharmaceuticals

    • Synergy Pharmaceuticals

    • Novartis Pharma

    • Yuhan Corp

    • Bama-Geve

    • Synthetic Biologics

    • Abbott Laboratories

    • Albireo Pharma

    By Type:

    • Linaclotide

    • Lubiprostone

    • Osmotic Laxatives

    • Stimulant Laxatives

    • Other

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of IBS-C Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe IBS-C Drug Market Size and Growth Rate of Linaclotide from 2014 to 2026

    • 1.3.2 Europe IBS-C Drug Market Size and Growth Rate of Lubiprostone from 2014 to 2026

    • 1.3.3 Europe IBS-C Drug Market Size and Growth Rate of Osmotic Laxatives from 2014 to 2026

    • 1.3.4 Europe IBS-C Drug Market Size and Growth Rate of Stimulant Laxatives from 2014 to 2026

    • 1.3.5 Europe IBS-C Drug Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe IBS-C Drug Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • 1.4.2 Europe IBS-C Drug Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • 1.4.3 Europe IBS-C Drug Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany IBS-C Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK IBS-C Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France IBS-C Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy IBS-C Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain IBS-C Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland IBS-C Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia IBS-C Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland IBS-C Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey IBS-C Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) IBS-C Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) IBS-C Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of IBS-C Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of IBS-C Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Linaclotide

      • 3.4.2 Market Size and Growth Rate of Lubiprostone

      • 3.4.3 Market Size and Growth Rate of Osmotic Laxatives

      • 3.4.4 Market Size and Growth Rate of Stimulant Laxatives

      • 3.4.5 Market Size and Growth Rate of Other

    4 Segmentation of IBS-C Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of IBS-C Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of IBS-C Drug for Hospital Pharmacies

      • 4.4.2 Market Size and Growth Rate of IBS-C Drug for Retail Pharmacies

      • 4.4.3 Market Size and Growth Rate of IBS-C Drug for Online Pharmacies

    5 Market Analysis by Major Regions

    • 5.1 Europe IBS-C Drug Production Analysis by Top Regions

    • 5.2 Europe IBS-C Drug Consumption Analysis by Top Regions

    • 5.3 Europe IBS-C Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany IBS-C Drug Production, Import, Consumption and Export Analysis

      • 5.3.2 UK IBS-C Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 France IBS-C Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy IBS-C Drug Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain IBS-C Drug Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland IBS-C Drug Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia IBS-C Drug Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland IBS-C Drug Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey IBS-C Drug Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) IBS-C Drug Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) IBS-C Drug Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) IBS-C Drug Production, Import, Consumption and Export Analysis

    6 Product Circulation of IBS-C Drug Market among Top Countries

    • 6.1 Top 5 Export Countries in IBS-C Drug Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in IBS-C Drug Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in IBS-C Drug Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in IBS-C Drug Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in IBS-C Drug Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in IBS-C Drug Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany IBS-C Drug Landscape Analysis

    • 7.1 Germany IBS-C Drug Landscape Analysis by Major Types

    • 7.2 Germany IBS-C Drug Landscape Analysis by Major End-Users

    8. UK IBS-C Drug Landscape Analysis

    • 8.1 UK IBS-C Drug Landscape Analysis by Major Types

    • 8.2 UK IBS-C Drug Landscape Analysis by Major End-Users

    9. France IBS-C Drug Landscape Analysis

    • 9.1 France IBS-C Drug Landscape Analysis by Major Types

    • 9.2 France IBS-C Drug Landscape Analysis by Major End-Users

    10. Italy IBS-C Drug Landscape Analysis

    • 10.1 Italy IBS-C Drug Landscape Analysis by Major Types

    • 10.2 Italy IBS-C Drug Landscape Analysis by Major End-Users

    11. Spain IBS-C Drug Landscape Analysis

    • 11.1 Spain IBS-C Drug Landscape Analysis by Major Types

    • 11.2 Spain IBS-C Drug Landscape Analysis by Major End-Users

    12. Poland IBS-C Drug Landscape Analysis

    • 12.1 Poland IBS-C Drug Landscape Analysis by Major Types

    • 12.2 Poland IBS-C Drug Landscape Analysis by Major End-Users

    13. Russia IBS-C Drug Landscape Analysis

    • 13.1 Russia IBS-C Drug Landscape Analysis by Major Types

    • 13.2 Russia IBS-C Drug Landscape Analysis by Major End-Users

    14. Switzerland IBS-C Drug Landscape Analysis

    • 14.1 Switzerland IBS-C Drug Landscape Analysis by Major Types

    • 14.2 Switzerland IBS-C Drug Landscape Analysis by Major End-Users

    15. Turkey IBS-C Drug Landscape Analysis

    • 15.1 Turkey IBS-C Drug Landscape Analysis by Major Types

    • 15.2 Turkey IBS-C Drug Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) IBS-C Drug Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) IBS-C Drug Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) IBS-C Drug Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) IBS-C Drug Landscape Analysis by Top Countries

      • 16.3.1 Denmark IBS-C Drug Market Volume and Growth Rate

      • 16.3.2 Finland IBS-C Drug Market Volume and Growth Rate

      • 16.3.3 Norway IBS-C Drug Market Volume and Growth Rate

      • 16.3.4 Sweden IBS-C Drug Market Volume and Growth Rate

      • 16.3.6 Iceland IBS-C Drug Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) IBS-C Drug Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) IBS-C Drug Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) IBS-C Drug Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) IBS-C Drug Landscape Analysis by Top Countries

      • 17.3.1 Belgium IBS-C Drug Market Volume and Growth Rate

      • 17.3.2 Netherlands IBS-C Drug Market Volume and Growth Rate

      • 17.3.3 Luxembourg IBS-C Drug Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) IBS-C Drug Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) IBS-C Drug Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) IBS-C Drug Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) IBS-C Drug Landscape Analysis by Top Countries

      • 18.3.1 Estonia IBS-C Drug Market Volume and Growth Rate

      • 18.3.2 Latvia IBS-C Drug Market Volume and Growth Rate

      • 18.3.3 Lithuania IBS-C Drug Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Catalent Pharmaceuticals Solutions

      • 19.1.1 Catalent Pharmaceuticals Solutions Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Ono Pharmaceutical

      • 19.2.1 Ono Pharmaceutical Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Ironwood Pharmaceuticals

      • 19.3.1 Ironwood Pharmaceuticals Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 The Menarini Group

      • 19.4.1 The Menarini Group Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Astrazeneca

      • 19.5.1 Astrazeneca Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Salix Pharmaceuticals

      • 19.6.1 Salix Pharmaceuticals Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Ardelyx

      • 19.7.1 Ardelyx Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Norgine

      • 19.8.1 Norgine Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Ferring BV

      • 19.9.1 Ferring BV Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Prometheus Laboratories

      • 19.10.1 Prometheus Laboratories Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Nestle

      • 19.11.1 Nestle Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Actavis Nordic

      • 19.12.1 Actavis Nordic Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Teva Pharmaceutical Industries

      • 19.13.1 Teva Pharmaceutical Industries Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Astellas Pharmaceuticals

      • 19.14.1 Astellas Pharmaceuticals Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Sucampo Pharmaceuticals

      • 19.15.1 Sucampo Pharmaceuticals Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Synergy Pharmaceuticals

      • 19.16.1 Synergy Pharmaceuticals Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Novartis Pharma

      • 19.17.1 Novartis Pharma Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Yuhan Corp

      • 19.18.1 Yuhan Corp Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Bama-Geve

      • 19.19.1 Bama-Geve Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Synthetic Biologics

      • 19.20.1 Synthetic Biologics Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Abbott Laboratories

      • 19.21.1 Abbott Laboratories Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Albireo Pharma

      • 19.22.1 Albireo Pharma Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    The List of Tables and Figures (Totals 70 Figures and 121 Tables)

    • Figure Product Picture

    • Figure Europe IBS-C Drug Market Size and Growth Rate of Linaclotide from 2014 to 2026

    • Figure Europe IBS-C Drug Market Size and Growth Rate of Lubiprostone from 2014 to 2026

    • Figure Europe IBS-C Drug Market Size and Growth Rate of Osmotic Laxatives from 2014 to 2026

    • Figure Europe IBS-C Drug Market Size and Growth Rate of Stimulant Laxatives from 2014 to 2026

    • Figure Europe IBS-C Drug Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Europe IBS-C Drug Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Europe IBS-C Drug Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Europe IBS-C Drug Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Figure Germany IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure UK IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure France IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Italy IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Spain IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Poland IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Russia IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Canada IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Finland IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Norway IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania IBS-C Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of IBS-C Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of IBS-C Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of IBS-C Drug by Different Types from 2014 to 2026

    • Table Consumption Share of IBS-C Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Linaclotide

    • Figure Market Size and Growth Rate of Lubiprostone

    • Figure Market Size and Growth Rate of Osmotic Laxatives

    • Figure Market Size and Growth Rate of Stimulant Laxatives

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of IBS-C Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of IBS-C Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Table Europe IBS-C Drug Production by Major Regions

    • Table Europe IBS-C Drug Production Share by Major Regions

    • Figure Europe IBS-C Drug Production Share by Major Countries and Regions in 2014

    • Table Europe IBS-C Drug Consumption by Major Regions

    • Table Europe IBS-C Drug Consumption Share by Major Regions

    • Table Germany IBS-C Drug Production, Import, Consumption and Export Analysis

    • Table UK IBS-C Drug Production, Import, Consumption and Export Analysis

    • Table France IBS-C Drug Production, Import, Consumption and Export Analysis

    • Table Italy IBS-C Drug Production, Import, Consumption and Export Analysis

    • Table Spain IBS-C Drug Production, Import, Consumption and Export Analysis

    • Table Poland IBS-C Drug Production, Import, Consumption and Export Analysis

    • Table Russia IBS-C Drug Production, Import, Consumption and Export Analysis

    • Table Switzerland IBS-C Drug Production, Import, Consumption and Export Analysis

    • Table Turkey IBS-C Drug Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) IBS-C Drug Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) IBS-C Drug Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) IBS-C Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in IBS-C Drug Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in IBS-C Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in IBS-C Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in IBS-C Drug Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany IBS-C Drug Consumption by Types from 2014 to 2026

    • Table Germany IBS-C Drug Consumption Share by Types from 2014 to 2026

    • Table Germany IBS-C Drug Consumption by End-Users from 2014 to 2026

    • Table Germany IBS-C Drug Consumption Share by End-Users from 2014 to 2026

    • Table UK IBS-C Drug Consumption by Types from 2014 to 2026

    • Table UK IBS-C Drug Consumption Share by Types from 2014 to 2026

    • Table UK IBS-C Drug Consumption by End-Users from 2014 to 2026

    • Table UK IBS-C Drug Consumption Share by End-Users from 2014 to 2026

    • Table France IBS-C Drug Consumption by Types from 2014 to 2026

    • Table France IBS-C Drug Consumption Share by Types from 2014 to 2026

    • Table France IBS-C Drug Consumption by End-Users from 2014 to 2026

    • Table France IBS-C Drug Consumption Share by End-Users from 2014 to 2026

    • Table Italy IBS-C Drug Consumption by Types from 2014 to 2026

    • Table Italy IBS-C Drug Consumption Share by Types from 2014 to 2026

    • Table Italy IBS-C Drug Consumption by End-Users from 2014 to 2026

    • Table Italy IBS-C Drug Consumption Share by End-Users from 2014 to 2026

    • Table Spain IBS-C Drug Consumption by Types from 2014 to 2026

    • Table Spain IBS-C Drug Consumption Share by Types from 2014 to 2026

    • Table Spain IBS-C Drug Consumption by End-Users from 2014 to 2026

    • Table Spain IBS-C Drug Consumption Share by End-Users from 2014 to 2026

    • Table Poland IBS-C Drug Consumption by Types from 2014 to 2026

    • Table Poland IBS-C Drug Consumption Share by Types from 2014 to 2026

    • Table Poland IBS-C Drug Consumption by End-Users from 2014 to 2026

    • Table Poland IBS-C Drug Consumption Share by End-Users from 2014 to 2026

    • Table Russia IBS-C Drug Consumption by Types from 2014 to 2026

    • Table Russia IBS-C Drug Consumption Share by Types from 2014 to 2026

    • Table Russia IBS-C Drug Consumption by End-Users from 2014 to 2026

    • Table Russia IBS-C Drug Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland IBS-C Drug Consumption by Types from 2014 to 2026

    • Table Switzerland IBS-C Drug Consumption Share by Types from 2014 to 2026

    • Table Switzerland IBS-C Drug Consumption by End-Users from 2014 to 2026

    • Table Switzerland IBS-C Drug Consumption Share by End-Users from 2014 to 2026

    • Table Turkey IBS-C Drug Consumption by Types from 2014 to 2026

    • Table Turkey IBS-C Drug Consumption Share by Types from 2014 to 2026

    • Table Turkey IBS-C Drug Consumption by End-Users from 2014 to 2026

    • Table Turkey IBS-C Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) IBS-C Drug Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) IBS-C Drug Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) IBS-C Drug Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) IBS-C Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) IBS-C Drug Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) IBS-C Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark IBS-C Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland IBS-C Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway IBS-C Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden IBS-C Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland IBS-C Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) IBS-C Drug Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) IBS-C Drug Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) IBS-C Drug Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) IBS-C Drug Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) IBS-C Drug Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) IBS-C Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium IBS-C Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands IBS-C Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg IBS-C Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) IBS-C Drug Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) IBS-C Drug Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) IBS-C Drug Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) IBS-C Drug Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) IBS-C Drug Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) IBS-C Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia IBS-C Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia IBS-C Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries IBS-C Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Catalent Pharmaceuticals Solutions

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Catalent Pharmaceuticals Solutions

    • Figure Sales and Growth Rate Analysis of Catalent Pharmaceuticals Solutions

    • Figure Revenue and Market Share Analysis of Catalent Pharmaceuticals Solutions

    • Table Product and Service Introduction of Catalent Pharmaceuticals Solutions

    • Table Company Profile and Development Status of Ono Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ono Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Ono Pharmaceutical

    • Figure Revenue and Market Share Analysis of Ono Pharmaceutical

    • Table Product and Service Introduction of Ono Pharmaceutical

    • Table Company Profile and Development Status of Ironwood Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Ironwood Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Ironwood Pharmaceuticals

    • Table Product and Service Introduction of Ironwood Pharmaceuticals

    • Table Company Profile and Development Status of The Menarini Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of The Menarini Group

    • Figure Sales and Growth Rate Analysis of The Menarini Group

    • Figure Revenue and Market Share Analysis of The Menarini Group

    • Table Product and Service Introduction of The Menarini Group

    • Table Company Profile and Development Status of Astrazeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astrazeneca

    • Figure Sales and Growth Rate Analysis of Astrazeneca

    • Figure Revenue and Market Share Analysis of Astrazeneca

    • Table Product and Service Introduction of Astrazeneca

    • Table Company Profile and Development Status of Salix Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Salix Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Salix Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Salix Pharmaceuticals

    • Table Product and Service Introduction of Salix Pharmaceuticals

    • Table Company Profile and Development Status of Ardelyx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ardelyx

    • Figure Sales and Growth Rate Analysis of Ardelyx

    • Figure Revenue and Market Share Analysis of Ardelyx

    • Table Product and Service Introduction of Ardelyx

    • Table Company Profile and Development Status of Norgine

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Norgine

    • Figure Sales and Growth Rate Analysis of Norgine

    • Figure Revenue and Market Share Analysis of Norgine

    • Table Product and Service Introduction of Norgine

    • Table Company Profile and Development Status of Ferring BV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring BV

    • Figure Sales and Growth Rate Analysis of Ferring BV

    • Figure Revenue and Market Share Analysis of Ferring BV

    • Table Product and Service Introduction of Ferring BV

    • Table Company Profile and Development Status of Prometheus Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Prometheus Laboratories

    • Figure Sales and Growth Rate Analysis of Prometheus Laboratories

    • Figure Revenue and Market Share Analysis of Prometheus Laboratories

    • Table Product and Service Introduction of Prometheus Laboratories

    • Table Company Profile and Development Status of Nestle

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nestle

    • Figure Sales and Growth Rate Analysis of Nestle

    • Figure Revenue and Market Share Analysis of Nestle

    • Table Product and Service Introduction of Nestle

    • Table Company Profile and Development Status of Actavis Nordic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis Nordic

    • Figure Sales and Growth Rate Analysis of Actavis Nordic

    • Figure Revenue and Market Share Analysis of Actavis Nordic

    • Table Product and Service Introduction of Actavis Nordic

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries

    • Table Product and Service Introduction of Teva Pharmaceutical Industries

    • Table Company Profile and Development Status of Astellas Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Astellas Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Astellas Pharmaceuticals

    • Table Product and Service Introduction of Astellas Pharmaceuticals

    • Table Company Profile and Development Status of Sucampo Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sucampo Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Sucampo Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Sucampo Pharmaceuticals

    • Table Product and Service Introduction of Sucampo Pharmaceuticals

    • Table Company Profile and Development Status of Synergy Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synergy Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Synergy Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Synergy Pharmaceuticals

    • Table Product and Service Introduction of Synergy Pharmaceuticals

    • Table Company Profile and Development Status of Novartis Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis Pharma

    • Figure Sales and Growth Rate Analysis of Novartis Pharma

    • Figure Revenue and Market Share Analysis of Novartis Pharma

    • Table Product and Service Introduction of Novartis Pharma

    • Table Company Profile and Development Status of Yuhan Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Yuhan Corp

    • Figure Sales and Growth Rate Analysis of Yuhan Corp

    • Figure Revenue and Market Share Analysis of Yuhan Corp

    • Table Product and Service Introduction of Yuhan Corp

    • Table Company Profile and Development Status of Bama-Geve

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bama-Geve

    • Figure Sales and Growth Rate Analysis of Bama-Geve

    • Figure Revenue and Market Share Analysis of Bama-Geve

    • Table Product and Service Introduction of Bama-Geve

    • Table Company Profile and Development Status of Synthetic Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synthetic Biologics

    • Figure Sales and Growth Rate Analysis of Synthetic Biologics

    • Figure Revenue and Market Share Analysis of Synthetic Biologics

    • Table Product and Service Introduction of Synthetic Biologics

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Albireo Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Albireo Pharma

    • Figure Sales and Growth Rate Analysis of Albireo Pharma

    • Figure Revenue and Market Share Analysis of Albireo Pharma

    • Table Product and Service Introduction of Albireo Pharma

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US